Benjamin Edwards Inc. Has $1.65 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Benjamin Edwards Inc. lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.1% in the second quarter, according to its most recent filing with the SEC. The firm owned 3,239 shares of the healthcare conglomerate’s stock after selling 445 shares during the period. Benjamin Edwards Inc.’s holdings in UnitedHealth Group were worth $1,649,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the business. Benjamin F. Edwards & Company Inc. grew its holdings in UnitedHealth Group by 4.8% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 39,031 shares of the healthcare conglomerate’s stock worth $19,877,000 after acquiring an additional 1,770 shares during the period. Ieq Capital LLC grew its holdings in UnitedHealth Group by 4.6% during the 2nd quarter. Ieq Capital LLC now owns 62,584 shares of the healthcare conglomerate’s stock worth $31,872,000 after acquiring an additional 2,775 shares during the period. Brighton Jones LLC grew its holdings in UnitedHealth Group by 47.4% during the 2nd quarter. Brighton Jones LLC now owns 26,302 shares of the healthcare conglomerate’s stock worth $13,394,000 after acquiring an additional 8,458 shares during the period. Intech Investment Management LLC boosted its position in shares of UnitedHealth Group by 1.0% during the second quarter. Intech Investment Management LLC now owns 337,254 shares of the healthcare conglomerate’s stock worth $171,750,000 after purchasing an additional 3,348 shares in the last quarter. Finally, Bristol Gate Capital Partners Inc. boosted its position in shares of UnitedHealth Group by 7.2% during the second quarter. Bristol Gate Capital Partners Inc. now owns 184,925 shares of the healthcare conglomerate’s stock worth $94,175,000 after purchasing an additional 12,372 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the stock. UBS Group lifted their price target on shares of UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research report on Thursday, July 18th. Robert W. Baird lifted their price target on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. HSBC lifted their price target on shares of UnitedHealth Group from $580.00 to $610.00 in a research report on Thursday, July 18th. Truist Financial boosted their price objective on shares of UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Finally, Argus boosted their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. One research analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $614.17.

UnitedHealth Group Trading Down 0.6 %

Shares of NYSE:UNH opened at $577.10 on Friday. The stock has a market capitalization of $532.91 billion, a PE ratio of 35.28, a price-to-earnings-growth ratio of 1.64 and a beta of 0.58. The company’s 50-day moving average price is $575.84 and its two-hundred day moving average price is $519.83. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $607.94. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping the consensus estimate of $6.66 by $0.14. The company had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. UnitedHealth Group’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period in the previous year, the business earned $6.14 EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be paid a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.46%. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.